Part,  Chapter, Paragraph

1   II,     5.  2.  4|             thanks to the introduction of statins, about 60% of patients with
2   II,     5.  2.  5| angiotensin-converting-enzyme inhibitors; statins etc) explain less than half
3   II,     5.  2.  6| angiotensin-converting-enzyme inhibitors; statins etc) explain less than half
4   II,     5.  2.  6|                   14 randomised trials of statins. Lancet 366: 1267-1278.~
5   II,     5.  2.  6|                    Pleiotropic effects of statins: benefit beyond cholesterol
6   II,     9        |            HMG-CoA) reductase inhibitors (statins), and angiotensin-converting
7   II,     9        |             HMG-CoA reductase inhibitors (statins) reduce risk for stroke,
8   II,     9.  3.  1|            HMG-CoA) reductase inhibitors (statins), and angiotensin-converting
9   II,     9.  3.  1|             HMG-CoA reductase inhibitors (statins) reduce risk for stroke,